Legend Biotech Corp ADR (LEGN): Next-Year EPS Estimate 950.63%
As of 2026-05-20, Legend Biotech Corp ADR (LEGN) has a next-year EPS growth estimate of 950.63%. Featured in 3 EPS revision reports, most recently on 2026-04-23.
On 2026-05-18, analyst consensus for LEGN's next-year EPS growth shifted from 905.32% to 950.63% — a positive change of 45.31 percentage points. The revised estimate has been sustained across 3 subsequent trading sessions. Current-year growth is projected at 110.63%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 950.63%
- EPS growth this year
- 110.63%
- EPS next quarter (est)
- $0.06
- Last price
- $28.12
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-20 | 950.63% | 110.63% | $0.06 | $28.12 |
| 2026-05-19 | 950.63% | 110.63% | $0.06 | $26.94 |
| 2026-05-18 | 950.63% | 110.63% | $0.06 | $26.98 |
| 2026-05-17 | 905.32% | 111.07% | $0.05 | $27.55 |
| 2026-05-14 | 830.77% | 112.17% | $0.05 | $28.60 |
| 2026-05-13 | 830.77% | 112.17% | $0.05 | $28.90 |
| 2026-05-12 | 375.96% | 125.33% | $0.06 | $28.26 |
| 2026-05-11 | 307.25% | 129.86% | $0.01 | $25.58 |
| 2026-05-10 | 307.25% | 129.86% | $0.01 | $28.12 |
| 2026-05-07 | 307.25% | 129.86% | $0.01 | $28.57 |
| 2026-05-06 | 307.25% | 129.86% | $0.01 | $28.96 |
| 2026-05-05 | 307.25% | 129.86% | $0.01 | $28.51 |
| 2026-05-04 | 307.25% | 129.86% | $0.01 | $26.50 |
| 2026-05-03 | 307.25% | 129.86% | $0.01 | $23.59 |
| 2026-04-30 | 307.25% | 129.86% | $0.01 | $23.52 |
| 2026-04-29 | 307.25% | 129.86% | $0.01 | $22.77 |
| 2026-04-28 | 307.25% | 129.86% | $0.01 | $23.56 |
| 2026-04-27 | 307.25% | 129.86% | $0.01 | $23.65 |
| 2026-04-26 | 307.25% | 129.86% | $0.01 | $23.90 |
| 2026-04-24 | 307.25% | 129.86% | $0.01 | $23.90 |
| 2026-04-23 | 307.25% | 129.86% | $0.01 | $23.99 |
| 2026-04-22 | 307.25% | 129.86% | $0.01 | $25.93 |
| 2026-04-21 | 307.25% | 129.86% | $0.01 | $25.22 |
| 2026-04-20 | 307.25% | 129.86% | $0.01 | $25.07 |
| 2026-04-19 | 312.32% | 129.49% | $0.01 | $21.17 |
| 2026-04-16 | 312.32% | 129.49% | $0.01 | $21.08 |
| 2026-04-15 | 312.32% | 129.49% | $0.01 | $20.52 |
| 2026-04-14 | 312.32% | 129.49% | $0.01 | $18.69 |
| 2026-04-13 | 311.88% | 129.42% | $0.01 | $17.69 |
| 2026-04-12 | 311.88% | 129.42% | $0.01 | $18.16 |
Reports Featuring LEGN
Recent News
Screen Performance
Aggregate stats across all 1713 tickers our top-EPS-revision screen has flagged over the past 49 days.
- Median return since detection
- +2.8%
- % of tickers in the green
- 58%
- Median return on winners
- +15.1%
- Large revisions captured
- 630
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Legend Biotech Corp ADR's next-year EPS growth estimate?▾
As of 2026-05-20, Legend Biotech Corp ADR (LEGN) has a next-year EPS growth estimate of 950.63%, based on analyst consensus.
When was the latest EPS estimate revision for LEGN?▾
The most recent revision occurred on 2026-05-18, when analysts adjusted the next-year EPS growth estimate from 905.32% to 950.63%.
What sector and industry does Legend Biotech Corp ADR belong to?▾
Legend Biotech Corp ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. LEGN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Legend Biotech Corp ADR (LEGN) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports